Assessment of drug induced developmental toxicity using human embryonic stem cells

Cell Biology International

Volumn 32, Issue 11, 2008, Pages 1412-1424

  Mehta, Ashish ^a   Konala, Vijay Bhaskar R ^a   Khanna, Aparna ^a   Majumdar, Anish S ^a  

^a RELIANCE LIFE SCIENCES PVT LTD   (India)

Author keywords

Developmental toxicity; Embryoid bodies; Gene expression; Human embryonic stem cells

Indexed keywords

BUSULFAN; CAFFEINE; HYDROXYUREA; INDOMETACIN; PENICILLIN G; SACCHARIN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DEVELOPMENTAL TOXICITY; DRUG CYTOTOXICITY; DRUG INDUCED DISEASE; EMBRYONIC STEM CELL; EMBRYOTOXICITY; GENE EXPRESSION; GERM LAYER; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN;

ANIMALS; CELL LINE; CELLS, CULTURED; COLONY-FORMING UNITS ASSAY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; DRUG TOXICITY; EMBRYONIC DEVELOPMENT; EMBRYONIC STEM CELLS; FIBROBLASTS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GERM LAYERS; HUMANS; MICE; RNA, MESSENGER; SPHEROIDS, CELLULAR; TERATOGENS;

MAMMALIA;

EID: 54049083761     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellbi.2008.08.012     Document Type: Article

References (43)

1. Akima S., Kent A., Reynolds G.J., Gallagher M., and Falk M.C. Indomethacin and renal impairment in neonates. Pediatr Nephrol 19 (2004) 490-493
2. Baharvand H., Hashime S.M., Ashtiani S.K., and Farrokhi A. Differentiation of human embryonic stem cells into hepatocytes in 2D and 3D culture systems in vitro. Int J Dev Biol 50 (2006) 645-652
3. Bhattacharya B., Cai J., Luo Y., Miura T., Mejido J., Brimble S.N., et al. Comparison of the gene expression profile of undifferentiated human embryonic stem cell lines and differentiating embryoid bodies. BMC Dev Biol 5 (2005) 22
4. Bremer S., Worth A.P., Paparella M., Bigot K., Kolossov E., Fleischmann B.K., et al. Establishment of an in vitro reporter assay for the development of cardiac toxicity. Toxicol In Vitro 15 (2001) 215-223
5. Brimble S.N., Zeng X., Weiler D.A., Luo Y., Liu Y., Lyons I.G., et al. Karyotypic stability, genotyping, differentiation, feeder free maintenance, and gene expression sampling in three human embryonic stem cell lines derived prior to August 9, 2001. Stem Cells Dev 13 (2004) 585-597
6. Busen R., Visan A., Genschow E., Slawik B., Spielmann H., and Seiler A. Trends in improving the embryonic stem cell test (EST): an overview. ALTEX 21 (2004) 15-22
7. Cai J., Liu Y.L., Miura T., Luo Y., Loring J.F., Freed W.J., et al. Assessing self-renewal and differentiation in human embryonic stem cell lines. Stem Cells 24 (2006) 516-530
8. Carpenter M.K., Rosler E., and Rao M.S. Characterization and differentiation of human embryonic stem cells. Cloning Stem Cells 5 (2003) 79-88
9. Chapin R., Stedman D., Paquette J., Streck R., Kumpf S., and Deng S. Struggles for equivalence: in vitro developmental model evolution in pharmaceuticals in 2006. Toxicol In Vitro 21 (2007) 1545-1551
10. Classen W., Krinke G.J., and Weber E. Developmental neurotoxicity study in rats: a positive control study with dimethylmercury and hydroxyurea. Neurotoxicology 22 (2001) 530
11. Denning C., Allegruci C., Priddle H., Barbadillo Munoz M.D., Anderson D., Self T., et al. Common culture conditions for maintenance and cardiomyocyte differentiation of human embryonic stem cells, BG01 and HUES-7. Int J Dev Biol 50 (2006) 27-37
12. Doetschmann T.C., Eistetter H., Katz M., Schmidt W., and Kemler R. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of a vesiceral yolk sac, blood islands and myocardium. J Embryol Exp Morphol 87 (1985) 27-45
13. Emmanouil E.N., Frangou H., Nikoloussis E., Manthou M.E., Lycartsis C., Massouridou S., et al. Histological and functional disorganisation in pregnant mice liver treated with all trans retinonic acid and hydroxyurea. Reprod Toxicol 20 (2005) 460-461
14. Genschow E., Scholz G., Brown N., Piersma A., Brady M., Clemann N., et al. Development of prediction models for three in vitro embryotoxicity tests in an ECVAM validation study. In Vitro Mol Toxicol 13 (2000) 51-65
15. Genschow E., Spielmann H., Scholz G., Pohl I., Seiler A., Clemann N., et al. Validation of the embryonic stem cells test in the international ECVAM validation study on three in vitro embryotoxicity tests. ATLA 32 (2004) 209-244
16. Gulati D., Russell V., Hommel L., Poonacha K., and Sabharwal P. Sodium saccharin. Environ Health Perspect 105 (1997) 347-348
17. Hoffman L.M., and Carpenter M.K. Characterization and culture of human embryonic stem cells. Nat Biotechnol 23 (2005) 699-708
18. Hvidberg E., Lausen H.H., and Jansen J.A. Indomethacin: plasma concentration and protein binding in man. Eur J Clin Pharmacol 4 (1972) 119-124
19. Kuller J.A., Laifer S.A., Molina R.D., Brown Y.L., and Younis E. The effects of indomethacin on maternal and fetal renal histology in rabbits. J Perinat Med 18 (1990) 59
20. ®hES1. Differentiation 74 (2006) 1-10
21. McNeish J. Embryonic stem cells in drug discovery. Nat Rev 3 (2004) 70-80
22. Mitalipova M.M., Rao R.R., Hoyer D.M., Johnson J.A., Meisner L.F., Jones K.L., et al. Preserving the genetic integrity of human embryonic stem cells. Nat Biotechnol 23 (2005) 19-20
23. Murabe M., Yamauchi J., Fujiwara Y., Hiroyama M., Sanbe A., and Tanoue A. A novel embryotoxic estimation method of VPA using ES cell differentiating system. Biochem Biophys Res Comm 352 (2007) 164-169
24. Murter T.E., Coller J., Claviez A., Schonberger F., Hofmann U., Dreger P., et al. Sensitive and rapid quantification of busulfan in small plasma volumes by liquid chromatography-electrospray mass spectrometry. Clin Chem 47 (2001) 1437-1442
25. Noaksson K., Zoric N., Zeng X., Rao M.S., Hyllner J., Semb H., et al. Monitoring differentiation of human embryonic stem cells using real-time PCR. Stem Cells 23 (2005) 1460-1467
26. ®ES1 under low serum concentration supplemented with BMP2. Differentiation 75 (2007) 112-122
27. Pal R., Mandal A., Rao H.S., Rao M.S., and Khanna A. A panel of tests for characterization of human embryonic stem cells. Regen Med 2 (2007) 179-192
28. Paparella M., Kolossov B.K., Fleischmann B.K., Hescheler J., and Bremer S. The use of quantitative image analysis in the assessment of in vitro embryotoxicity end point based on a novel embryonic stem cell clone with endoderm-related GFP expression. Toxicol In Vitro 16 (2002) 589-597
29. Pencillin G Potassium Injection, USP. .
30. Pesce A.J., Rashkin M., and Kotagal U. Standards of laboratory practice: theophylline and caffeine monitoring. Clin Chem 44 (1998) 1124-1128
31. Richards M., Tan S.P., Tan J.H., Chan W.K., and Bongso A. The transcriptome profile of human embryonic stem cells as defined by SAGE. Stem Cells 22 (2004) 51-64
32. Schmidt M.M., Guan K., and Wobus A.M. Lithium influences differentiation and tissue specific gene expression of mouse embryonic stem cells in vitro. Int J Dev Biol 45 (2001) 421-429
33. Scholz G., Pohl I., Genschow E., Klemm M., and Spielmann H. Embryotoxicity screening using embryonic stem cells in vitro: correlation to in vivo teratogenicity. Cells Tissues Organs 165 (1999) 203-211
34. Seiler A., Viisan A., Buesen R., Genschow E., and Spielmann H. Improvement of an in vitro stem cell assay for developmental toxicity: the use of molecular endpoints in the embryonic stem cell test. Reprod Toxicol 18 (2004) 231-240
35. Shehata B.M., Bare J.B., Denton T.D., Habib M.N., and Black J.O. Premature closure of the ductus arteriosus: a variable response among monozygotic twins after in uteral exposure to indomethacin. Fetal Pediatr Pathol 25 (2006) 151-157
36. Spielmann H., Pohl I., Doring B., Liebsch M., and Moldenhauer F. The embryonic stem cell test, an in vitro embryotoxicity test using two permanent mouse cell lines: 3T3 fibroblast and embryonic stem cells. In Vitro Toxicol 10 (1997) 119-127
37. Theiler K. The house mouse development and normal stages from fertilization to 4 weeks of age. 2nd ed. (1989), Springer-Verlag, Berlin
38. Villani P., Maserati R., Regazzi M.B., Giacchino R., and Lori F. Pharmacokinetics of hydroxyurea in patients infected with human immunodeficiency virus type I. J Clin Pharmacol 36 (1996) 117-121
39. Wobus A.M., Rohwedel J., Maltsev V., and Hescheler J. In vitro diffferentiation of embryonic stem cells into cardiomyocytes or skeletal muscle cells is specifically modulated by retinoic acid. Roux's Arch Dev Biol 204 (1994) 36-45
40. Xu X., and Carpenter M.K. Human embryonic stem cells-derived cardiomyocytes. In: Chui A.Y., and Rao M.S. (Eds). Differentiation and characterization, Human embryonic stem cells (2003), Humana Press 181-199
41. Yoon B.S., Yoo S.J., Lee J.E., You S., Lee H.T., and Yoon H.S. Enhanced differentiation of human embryonic stem cells into cardiomyocytes by combining hanging drop culture and 5-azacytidine treatment. Differentiation 74 (2006) 149-159
42. Zeng X., Miura T., Luo Y., Bhattacharya B., Condie B., Chen J., et al. Properties of pluripotent human embryonic stem cells BG01 and BG02. Stem Cells 22 (2004) 292-312
43. Zur Nieden N.I., Kempka G., and Ahr H.J. Molecular multiple endpoint embryonic stem cell test- a possible approach to test for the teratogenic potential of compounds. Toxicol Appl Pharmacol 194 (2004) 257-269